MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 941 to 960 of 166,322 approvalsPage 48 of 8317

Perindopril tert-Butylamine Tablets

Approval Number: 国药准字H20253778
Registration: Apr 1, 2025

Ceftazidime and Avibactam Sodium for Injection

Approval Number: 国药准字H20253763
Registration: Apr 1, 2025

Oseltamivir Phosphate for Suspension

Approval Number: 国药准字H20253775
Registration: Apr 1, 2025

Arbidol Hydrochloride Tablets

Approval Number: 国药准字H20253794
Registration: Apr 1, 2025

Teicoplanin for Injection

Approval Number: 国药准字H20253762
Registration: Apr 1, 2025

Perindopril tert-Butylamine Tablets

Approval Number: 国药准字H20253777
Registration: Apr 1, 2025

Levocarnitine Oral Solution

Approval Number: 国药准字H20253799
Registration: Apr 1, 2025

Polyvinyl Alcohol Eye Drops

Approval Number: 国药准字H20253772
Registration: Apr 1, 2025

Beclometasone Dipropionate Suspension for Inhalation

Approval Number: 国药准字H20253765
Registration: Apr 1, 2025

CICLESONIDE INHALATION AEROSOL

Approval Number: 国药准字HJ20250035
Registration: Apr 1, 2025

Citicoline Sodium Injection

Approval Number: 国药准字H20258050
Registration: Apr 1, 2025

Glucosamine Sulfate Capsules

Approval Number: 国药准字H20253770
Registration: Apr 1, 2025

Pregabalin Oral Solution

Approval Number: 国药准字H20253751
Registration: Apr 1, 2025

Metformin Hydrochloride and Empagliflozin Tablets (Ⅰ)

Approval Number: 国药准字H20253795
Registration: Apr 1, 2025

Yangxue Anshen Tabbets

Approval Number: 国药准字Z14021128
Registration: Apr 1, 2025

Metformin Hydrochloride and Empagliflozin Tablets(Ⅵ)

Approval Number: 国药准字H20253796
Registration: Apr 1, 2025

Ertapenem Sodium for Injection

Approval Number: 国药准字HC20250005
Registration: Apr 1, 2025
松瑞制药股份有限公司

Betahistine Mesilate Tablets

Approval Number: 国药准字H20253804
Registration: Apr 1, 2025

Peramivir Injection

Approval Number: 国药准字H20253769
Registration: Apr 1, 2025

CICLESONIDE INHALATION AEROSOL

Approval Number: 国药准字HJ20250036
Registration: Apr 1, 2025
covis pharma gmbhcovis pharma gmbh

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.